Home » Covid vaccines, the EU: yes to the fourth dose to the fragile but the EMA warns: “The booster against Omicron is good but beware of multiple references”

Covid vaccines, the EU: yes to the fourth dose to the fragile but the EMA warns: “The booster against Omicron is good but beware of multiple references”

by admin

Important discussion with EU health ministers for a common response to Covid. “The science is clear on the next steps for citizens to take: increasing the spread of vaccination and providing an additional booster, especially for the most vulnerable.” The EU Commissioner for Health Stella Kyriades writes in a tweet while the extraordinary meeting of the 27 European ministers, convened by the French presidency, begins.

But it is so? If on the one hand the need for a fourth dose is recognized in particular on the frail – and Israel has already started the administration – on the other, there are questions about the advisability of multiple recalls. Ema comes to our aid and explains that “the booster is fine” but we must “avoid too many calls”

Vaccines work with Omicron

A report on anti-Covid vaccines, on the issue of efficacy against the Omicron variant of Sars-CoV-2, but also on how to face the future and which shield products will be needed to manage Covid-19 in the long term. Signed: drug agencies around the world, including the European Ema. Here is the document. But the EMA warns: “By examining data on the impact of Omicron it is becoming increasingly clear that a booster dose is needed to extend vaccine protection.” But looking at “possible vaccination approaches against Omicron and other variants”, the regulators agreed that “the administration of multiple booster doses at short intervals of time is not a sustainable long-term approach”.

These are the fixed points put in black and white in the report drawn up after the world summit which was held under the aegis of the International Coalition of Medicines Regulatory Authorities (ICMRA) on 12 January. Based on the data available on Omicron, the regulatory authorities reiterated, the conclusion is that “current vaccines offer less protection against infections and mild diseases caused by this variant. However, they continue to offer considerable protection from hospitalization and severe Covid-19, especially after a booster dose “. But for the experts the solution is not repeating boosters every few months. «It is necessary to develop a long-term strategy on the types of vaccines needed to manage Covid-19 in the future. This is an ongoing global discussion, which is at the crossroads of science, public policy and public health and will require coordination between decision-makers on the matter at all levels “, is highlighted in a note following the meeting. chaired by EMA and the American Fda, which was also attended by representatives of the World Health Organization. On that occasion, the experts had stressed the need to align from a regulatory point of view to accelerate and simplify the global development and authorization of any new or modified Covid vaccines against the emerging variants of the Sars-CoV-2 coronavirus.

See also  Medalla, review of his album Duelo (2023)

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy